ArticleProceedings of the National Academy of Sciences of the United States of America2025

Analgesia through FKBP51 inhibition at disease onset confers lasting relief from sensory and emotional chronic pain symptoms.

Sara Hestehave et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.